NCT00326053已完成3 期
A Comparison of Budesonide/Formoterol Turbuhaler® 160/4.5 µg 2 Inhalations BID Plus as Needed to Budesonide Turbuhaler® 320 µg 2 Inhalations BID Plus Terbutaline Turbuhaler® 0.4 mg as Needed for the Prevention of Asthma Relapse
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 600
- 试验地点
- 21
- 主要终点
- Time to first asthma relapse
研究概览
简要总结
The purpose of this study is to compare the Symbicort® Turbuhaler® to both Pulmicort® Turbuhaler® and Bricanyl® Turbuhaler® for the treatment of asthma after discharge from the emergency room
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 - 65 years of age
- •Presenting at a study emergency department with an asthma exacerbation
排除标准
- •Admission to hospital
- •Patients receiving more than 2000 µg/day of beclomethasone equivalent inhaled corticosteroids (1000 µg/day fluticasone or 1600 µg/day budesonide)
结局指标
主要结局
Time to first asthma relapse
次要结局
- Complete AE and SAE collection
- Mean use of reliever medication
- Asthma Control Questionnaire (ACQ) score
研究者
研究点 (21)
Loading locations...
相似试验
已完成
3 期
A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With AsthmaAsthmaNCT02224157AstraZeneca4,215
已完成
3 期
A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma.AsthmaNCT02149199AstraZeneca3,850
已完成
不适用
Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily PracticeAsthmaNCT00782314AstraZeneca400
已完成
1 期
Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort TurbuhalerAsthmaNCT01593826Orion Corporation, Orion Pharma72
已完成
1 期
Comparison of Budesonide and Formoterol Absorption From Budesonide/Formoterol Easyhaler and Symbicort TurbuhalerAsthmaNCT01386996Orion Corporation, Orion Pharma74